| For: | Sampaio MM, Santos MLC, Marques HS, Gonçalves VLS, Araújo GRL, Lopes LW, Apolonio JS, Silva CS, Santos LKS, Cuzzuol BR, Guimarães QES, Santos MN, de Brito BB, da Silva FAF, Oliveira MV, Souza CL, de Melo FF. Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review. World J Clin Oncol 2021; 12(2): 69-94 [PMID: 33680875 DOI: 10.5306/wjco.v12.i2.69] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i2/69.htm |
| Number | Citing Articles |
| 1 |
Laras Pratiwi, Fawzia Hanum Mashudi, Mukti Citra Ningtyas, Henry Sutanto, Pradana Zaky Romadhon. Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future Perspectives. Hematology Reports 2025; 17(2) doi: 10.3390/hematolrep17020018
|
| 2 |
Kelvyn M. L. Rocha, Érica C. M. Nascimento, João B. L. Martins. Under ONIOM Layers: Analysis of BCR-ABL Enzyme Inhibitors Through Bond-Critical Points and Natural Orbitals. Molecules 2025; 30(20) doi: 10.3390/molecules30204145
|
| 3 |
Alyaa Mohamed Ghoneem, Eman A. Soliman, Shaimaa El-Ashwah, Mohammed El Agdar, Hasan Abdel-Ghaffar. Utility of T315I mutation in Egyptian patients with chronic myeloid leukemia. Egyptian Journal of Basic and Applied Sciences 2024; 11(1) doi: 10.1080/2314808X.2024.2317021
|
| 4 |
Alice de Freitas Gomes, Adriane Dâmares de Souza Jorge Batalha, Carlos Eduardo de Castro Alves, Renata Galvão de Azevedo, Jesus Rafael Rodriguez Amado, Tatiane Pereira de Souza, Hector Henrique Ferreira Koolen, Felipe Moura Araújo da Silva, Francisco Celio Maia Chaves, Serafim Florentino Neto, Antônio Luiz Boechat, Gemilson Soares Pontes. Immunomodulatory and Anticancer Effects of Fridericia chica Extract-Loaded Nanocapsules in Myeloid Leukemia. Pharmaceutics 2024; 16(6) doi: 10.3390/pharmaceutics16060828
|
| 5 |
Fabeha Zafar, FNU Poombal, Laraib Ashraf, Divya Shivakumar, Diptish Wankhade, Rahul Winayak, Ghulam Mustafa Ali Malik, Shruti Sagar Mahapatra, Shasan G.C., Truc Huynh, Maneeth Mylavarapu. Nilotinib Versus Imatinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs). Cureus 2025; doi: 10.7759/cureus.82631
|
| 6 |
Ahmad Mir Hosseini, Shiva Dianaty, Sara Shahhosseini, Reza Biglarifard, Razieh Razmi, Nima Komeili, Danial Soltani. Advances in Nanotechnology for Enhanced Leukemia Therapy: A Systematic Review of In Vivo Studies. Journal of Lab Animal Research 2023; 2(6) doi: 10.58803/jlar.v2i6.34
|
| 7 |
Francisco Cezar Aquino de Moraes, Gustavo Tadeu Freitas Uchôa Matheus, Luis Henrique Rios Moreira Rego, Vitor Kendi Tsuchiya Sano, Jennifer Bayona Gazabón, Rommel Mario Rodríguez Burbano. Do genetic polymorphisms influence imatinib trough concentrations in patients with chronic myeloid leukemia? A systematic review and meta-analysis. Expert Review of Anticancer Therapy 2026; 26(5) doi: 10.1080/14737140.2025.2602802
|
| 8 |
Biswajit Bhuyan, Somanath Padhi, Probodha Kumar Das, Chinmayee Panigrahi. Leukemia - From Biology to Clinic. 2023; doi: 10.5772/intechopen.108334
|
| 9 |
D. Yahya, V. Miteva, I. Micheva, T. Ruseva, L. Angelova. Cytogenetic Analysis of Patients with Hematological Malignancies. Cytology and Genetics 2023; 57(3) doi: 10.3103/S0095452723030106
|
| 10 |
Nur Haida Natasha Shamsuddin, Abdul Rahman Azhari, Muhamad Amir Azizan, Hanis Nabilah Mohd Nazman, Zainul Abeden, Fadly Ahid, Narazah Mohd Yusoff, Asmida Isa. Cytogenetic profile of leukemia cases in northern region of Malaysia - A single centre retrospective study. Asia Pacific Journal of Molecular Biology and Biotechnology 2024; doi: 10.35118/apjmbb.2024.032.4.06
|
| 11 |
Areej Emad Kadhom, Ikbal Mohamad Hachim Al-Maadheed, Zahraa Akram Thabit. Immunohistochemical expression of BCL-2 oncogene in chronic myeloid leukemia in Iraqi patients. Iraqi Journal of Hematology 2025; 14(2) doi: 10.4103/ijh.ijh_47_25
|
| 12 |
Sarah Gado, Mohammed Al-Kassim Hassan, Mehmet Murat Kisla, Zeynep Ates-Alagoz. Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia. Medicinal Chemistry 2025; 21(7) doi: 10.2174/0115734064311341240929175508
|
| 13 |
Tyler Medina, Seán O. Hynes, Maeve Lowery, Patrick Gillespie, Walter Kolch, Cathal Seoighe. Overview of Molecular Diagnostics in Irish Clinical Oncology. HRB Open Research 2025; 7 doi: 10.12688/hrbopenres.13822.2
|
| 14 |
Zafar Iqbal, Muhammad Absar, Tanveer Akhtar, Aamer Aleem, Abid Jameel, Sulman Basit, Anhar Ullah, Sibtain Afzal, Khushnooda Ramzan, Mahmood Rasool, Sajjad Karim, Zeenat Mirza, Mudassar Iqbal, Maryam AlMajed, Buthinah AlShehab, Sarah AlMukhaylid, Nouf AlMutairi, Nawaf Al-anazi, Muhammad Farooq Sabar, Muhammad Arshad, Muhammad Asif, Masood Shammas, Amer Mahmood. Integrated Genomic Analysis Identifies ANKRD36 Gene as a Novel and Common Biomarker of Disease Progression in Chronic Myeloid Leukemia. Biology 2021; 10(11) doi: 10.3390/biology10111182
|
| 15 |
Shikha Verma, Aditi Sharan. Unveiling the Biomarkers: Identifying Key Signatures for Cancer Hallmarks. EAI Endorsed Transactions on Pervasive Health and Technology 2024; 10 doi: 10.4108/eetpht.10.5649
|
| 16 |
Basma Atef, Shaimaa El-Ashwah, Layla M. Saleh, Hanan Gawish, Mohamed Mabed. Potential utility of PPARγ agonists in targeting chronic myeloid leukemia stem cells. Annals of Hematology 2026; 105(4) doi: 10.1007/s00277-026-06795-7
|
| 17 |
Seiichi Okabe, Yuya Arai, Akihiko Gotoh, Daigo Akahane. Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia. Cancer Innovation 2025; 4(5) doi: 10.1002/cai2.70024
|
| 18 |
Sagar Sanjiv Desai, Febina Ravindran, Amey Panchal, Nishit Ojha, Sachin Jadhav, Bibha Choudhary. Whole transcriptome sequencing reveals HOXD11-AGAP3, a novel fusion transcript in the Indian acute leukemia cohort. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1100587
|
| 19 |
Yuvaraj Sivamani, Gowthami Venkataramanappa, Harshatha N. Reddy, Sanjana N. Deshpande, Keerthi Gopal, Sumitha Elayaperumal, Dhruv Rao. Advancing Science and Innovation in Healthcare Research. 2025; doi: 10.1016/B978-0-443-33351-4.00009-X
|
| 20 |
Zahraa A. Abdulrazaq, Mushtak T.S. Al-Ouqaili, Nabeel M. Talib. The impact of circulating 25-hydroxyvitamin D and vitamin D receptor variation on leukemia-lymphoma outcome: Molecular and cytogenetic study. Saudi Journal of Biological Sciences 2024; 31(1) doi: 10.1016/j.sjbs.2023.103882
|
| 21 |
Nima Torabi Fard, Melika Khademi, Aryan Salahi‐Niri, Shadi Esmaeili. Nanotechnology in Hematology: Enhancing Therapeutic Efficacy With Nanoparticles. Health Science Reports 2025; 8(5) doi: 10.1002/hsr2.70647
|
| 22 |
Udip Maheshwari, Disha Morzaria, Vashishth Maniar, Kunal Sehgal, Manjusha Ray, Vasudha Kaul. Isolated Central Nervous System blast crisis in chronic myeloid leukemia: A rare case report. Asian Journal of Oncology 2025; 11 doi: 10.25259/ASJO_9_2025
|
| 23 |
Asma Khan, Urooj Fatima, Urooj Zaidi, Attiya Munir, Hina Aslam. Pharmacogenomic Insights Into The Response To Imatinib In Chronic Myeloid Leukaemia: The Role Of CYP3A4 Polymorphisms. Journal of Rawalpindi Medical College 2025; 29(4) doi: 10.37939/jrmc.v29i4.2975
|
| 24 |
Michaela Domsicova, Simona Kurekova, Andrea Babelova, Kristina Jakic, Iveta Oravcova, Veronika Nemethova, Filip Razga, Albert Breier, Miroslav Gal, Alexandra Poturnayova. Advancements in Chronic Myeloid Leukemia detection: Development and evaluation of a novel QCM aptasensor for use in clinical practice. Biochemistry and Biophysics Reports 2024; 39 doi: 10.1016/j.bbrep.2024.101816
|
| 25 |
Neelam Sharma, Sukhbir Singh, Tapan Behl, Sandeep Arora, Philips Kumar, Sakshi Verma, Sumeet Gupta, Ladli Kishore. Emerging Trends in Cancer Pharmacology. 2026; doi: 10.1016/B978-0-443-31592-3.00004-2
|
| 26 |
Kawthar Ali Radhi, Bassam Francis Matti, Israa Hussein Hamzah. The role of miRNA- 96 and miRNA-150 between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients. Human Gene 2023; 36 doi: 10.1016/j.humgen.2023.201166
|
| 27 |
Subham Sarkar, Souvik Roy, Lopamudra Choudhury. Exosomes-mediated intercellular communication and their theragnostic potential against cancer and related disorders: a comprehensive review. Biotechnology Letters 2026; 48(3) doi: 10.1007/s10529-026-03738-0
|
| 28 |
Sara Benchikh, Soro Somda Georgina Charlène, Amale Bousfiha, Lunda Razoki, Jamila Aboulfaraj, Latifa Zarouf, Adil El Hamouchi, Abderrahim Malki, Sanaa Nassereddine. Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco. Annals of Hematology 2024; 103(8) doi: 10.1007/s00277-024-05747-3
|
| 29 |
Ying Liu, Taoyan Lin, Boxin Zhao, Yilei Li, Ping Zheng. Correlation analysis between plasma concentration of nilotinib and clinical efficacy and safety in patients with chronic myeloid leukemia: a single–center retrospective cohort study. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1676800
|
| 30 |
Ian Nykaza, Tania Platero-Portillo, Ellin Berman, Mark B. Geyer, Jae H. Park, Konstantinos Linos, Alina Markova. Histopathologic and Clinical Characteristics of Cutaneous Toxicities of Tyrosine Kinase Inhibitors: Insights Into Pathologic Mechanisms From a Retrospective Cohort. The American Journal of Dermatopathology 2025; 47(12) doi: 10.1097/DAD.0000000000003125
|
| 31 |
Hamed Soleimani Samarkhazan, Mohammad Navid Khaksari, Amirhossein Mirzazadeh, Mohammad Siavashi, Niloofar Pilehvari, Mohammad Hossein Mohammadi. Nanosensors in Leukemia Management: Pioneering Real‐Time Biomarker Detection for Precision Oncology. Nano Select 2025; 6(12) doi: 10.1002/nano.70039
|
| 32 |
Lijuan Zhu, Wei Zha, Jiajia Zhuo, Xia Yu. A case of T-cell acute lymphoblastic leukemia with co-occurrence of NUP214-ABL1 fusion and tetraploidy. Cancer Genetics 2025; doi: 10.1016/j.cancergen.2025.02.009
|
| 33 |
Aleena K S Arakaki, Frank Szulzewsky, Mark R Gilbert, Taranjit S Gujral, Eric C Holland. Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers. Neuro-Oncology 2021; 23(Supplement_5) doi: 10.1093/neuonc/noab183
|
| 34 |
Kawthar Ali Radhi, Israa Hussein Hamzah, Bassam Francis Matti. The role of miRNA -181C between different BCR-ABL p210 transcript levels and between different levels of imatinib optimal response in CML patients. Human Gene 2022; 34 doi: 10.1016/j.humgen.2022.201128
|
| 35 |
H. Al-Nayyar, K. Ben-Mahrez. GPX1 genetic variants rs2107819200 and rs1575633487 in disease status and tyrosine kinase inhibitor response in chronic myeloid leukemia patients. Regulatory Mechanisms in Biosystems 2025; 16(3) doi: 10.15421/0225128
|
| 36 |
Amma Anima Benneh-Akwasi Kuma, Michael Mauro. Modernising diagnosis and treatment of Chronic Myeloid Leukaemia for improved patient outcomes in a resource-limited setting: Experiences from Ghana’s premier teaching hospital. Journal of Interventional Epidemiology and Public Health 2026; 9(1) doi: 10.37432/jieph-d-25-00274
|
| 37 |
Tyler Medina, Seán O. Hynes, Maeve Lowery, Patrick Gillespie, Walter Kolch, Cathal Seoighe. Overview of Molecular Diagnostics in Irish Clinical Oncology. HRB Open Research 2024; 7 doi: 10.12688/hrbopenres.13822.1
|
| 38 |
Dean G. Brown. A Drug Discovery Perspective on FDA Expedited Development and Incentive Programs. Journal of Medicinal Chemistry 2024; 67(3) doi: 10.1021/acs.jmedchem.3c02165
|
| 39 |
Dena Panovska, Frederik De Smet. Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?. International Journal of Molecular Sciences 2022; 23(15) doi: 10.3390/ijms23158637
|
| 40 |
Sameen Shahid, Muhammad Farooq Sabar, Zafar Iqbal. Experimental Validation and Computational Deconstruction of Downstream Mutations in MIR5195: Integrating Whole-Exome Sequencing, Structural Dynamics, and Molecular Docking to Decipher Transcriptional Reprogramming in CML. Cell Biochemistry and Biophysics 2026; doi: 10.1007/s12013-026-02063-7
|
| 41 |
Darcy Tocci, Maiah Fogel, Vanya Gupta, Peter Kim, Jean Latimer, Aida Adlimoghaddam, Lisa S. Robison, Benedict C. Albensi. Beyond expectations: investigating nilotinib’s potential in attenuating neurodegeneration in Alzheimer’s disease. Alzheimer's Research & Therapy 2025; 17(1) doi: 10.1186/s13195-025-01706-w
|
| 42 |
Shalmali Pendse, Sayali Chavan, Vaijayanti Kale, Anuradha Vaidya. A comprehensive analysis of cell‐autonomous and non‐cell‐autonomous regulation of myeloid leukemic cells: The prospect of developing novel niche‐targeting therapies. Cell Biology International 2023; 47(10) doi: 10.1002/cbin.12078
|
| 43 |
Sameen Shahid, Zafar Iqbal, Muhammad Abbas Khokhar, Muhammad Farooq Sabar. Association of MUC3A P258S mutation with advanced phase CML structural and in silico insights. Functional & Integrative Genomics 2026; 26(1) doi: 10.1007/s10142-026-01871-7
|
| 44 |
Kavita Sangwan, Suman Khurana, Pratibha Dhakla. Imatinib Analogs in Chronic Myeloid Leukemia: a Systematic Qualitative Review. Current Pharmacology Reports 2023; 9(3) doi: 10.1007/s40495-023-00316-0
|
| 45 |
Lainee Swanson, Jonathan Sharp, Aliena Liaw, Delbert Abi Abdallah, David M Duriancik. Current Therapeutic Strategies for FLT3-Mutated Acute Myeloid Leukemia: A Narrative Review. Cureus 2025; doi: 10.7759/cureus.95338
|
| 46 |
Rojin Mansouri, Fatemeh Heydarpour, Kheirollah Yari, Maryam Naseroleslami, Mehrdad Payandeh. Study of the association between HDAC8, SIRT1, and P53 gene expression with drug resistance in chronic myeloid leukemia patients. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15070-3
|
| 47 |
Zhiyan Wang, Tingting Xu, Yiying Che, Jun-An Ma, Runqi Jin, Boao Mao, Xinru Lai, Kunrong Mei, Hongxia Zhao, Zhiguang Yuchi. ATTEC-mediated degradation of BCR-ABL in chronic myeloid leukemia cells. European Journal of Medicinal Chemistry 2026; 303 doi: 10.1016/j.ejmech.2025.118430
|
| 48 |
Niloofar Jaafari, Amir Asri Kojabad, Rima Manafi Shabestari, Majid Safa, Jian Wu. Design and fabrication of novel microfluidic-based droplets for drug screening on a chronic myeloid leukemia cell line. PLOS ONE 2025; 20(1) doi: 10.1371/journal.pone.0315803
|
| 49 |
. 2024; doi: 10.15626/LUD.544.2024
|
| 50 |
Fadwa M. AlKhulaifi, Afrah Alkhuriji, Lamjed Mansour, Abdullah Al-jurayyan, Norah M.A. Al-Mulhim, Yusra A. Tashkandy, Ghadeer S. Aldossari, Suliman Alomar. Association between Toll-like receptor 4 polymorphism and Acute Lymphoblastic Leukemia susceptibility in Saudi Arabian patients. Journal of King Saud University - Science 2022; 34(4) doi: 10.1016/j.jksus.2022.101985
|
| 51 |
Aya Abdulrahman Bahjat, Khder Hussein Rasul. Novel and recurrent mutations in exon 8 of natural killer group 2D (NKG2D) gene among chronic myeloid leukemia patients and their potential role in pathogenesis. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-11059-0
|
| 52 |
Setare Kheyrandish, Shiva Shadani, Aziz Eghbali, Behzad Poopak, Davood Bashash. BCR-ABL positive T cell Acute Lymphoblastic Leukemia (T-ALL): Exploring A Rare Case with A Comprehensive Review. Iranian Journal of Blood and Cancer 2024; 16(2) doi: 10.61186/ijbc.16.2.1
|
| 53 |
Kasumi Satoh, Saori Morisawa, Manabu Okuyama, Hajime Nakae. Severe pleural effusion associated with nilotinib for chronic myeloid leukaemia: cross-intolerance with tyrosine kinase inhibitors. BMJ Case Reports 2021; 14(9) doi: 10.1136/bcr-2021-243671
|
| 54 |
Sai Prasad Desikan, Sara Bresser, Alessandra Ferrajoli. Caring for the Female Cancer Patient. 2024; doi: 10.1017/9781009279864.018
|
| 55 |
Julhash U. Kazi. Python Essentials for Biomedical Data Analysis: An Introductory Textbook. 2025; doi: 10.1007/978-3-031-85600-6_10
|
| 56 |
Abdalla Fadul, Elmustafa Abdalla, Anas Mohamed, Bashir Ali, Nusiba Elamin, Ahmed Alsayed, Abdulrahman Al-Mashdali, Kalpana Singh, Shehab Mohamed. Elevated Vitamin B12 Levels in Myeloproliferative Neoplasm (MPN) Patients: A Potential Diagnostic and Prognostic Marker. Journal of Blood Medicine 2024; doi: 10.2147/JBM.S474393
|
| 57 |
Ayca Irgit, Reyhan Kamıs, Belgin Sever, Amaç Fatih Tuyun, Masami Otsuka, Mikako Fujita, Hasan Demirci, Halilibrahim Ciftci. Structure and Dynamics of the ABL1 Tyrosine Kinase and Its Important Role in Chronic Myeloid Leukemia. Archiv der Pharmazie 2025; 358(5) doi: 10.1002/ardp.70005
|
| 58 |
Hossein Bahari, Zeinab Salim, Leila Kardanpour, Hosein Kouchaki, Fatemeh Shoja, Iman Rahnama, Arezoo Faridzadeh, Maryam Ranjbar Zahedani. The Anti‐Leukemic Potential of Curcumin in Chronic Myeloid Leukemia: A Systematic Review of In Vitro Studies. Food Science & Nutrition 2025; 13(9) doi: 10.1002/fsn3.70852
|
| 59 |
Abdulbaki Yildirim, Hilal Akalin, Munis Dundar. Oncology: Genomics, Precision Medicine and Therapeutic Targets. 2023; doi: 10.1007/978-981-99-1529-3_2
|
| 60 |
Qianan Li, Xinxin Ren, Ying Wang, Xiaoru Xin. CircRNA: a rising star in leukemia. PeerJ 2023; 11 doi: 10.7717/peerj.15577
|
| 61 |
Pratistha Singh, Vinay Kumar Singh, Malkhey Verma. Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukemia treatment: Molecular docking and molecular dynamics simulation approaches. Biochemical and Biophysical Research Communications 2026; 796 doi: 10.1016/j.bbrc.2025.153115
|
| 62 |
Ruggero Lasala, Fiorenzo Santoleri. Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature. British Journal of Clinical Pharmacology 2022; 88(5) doi: 10.1111/bcp.15147
|
| 63 |
Yusur Falah Faraj. Polymorphism detection of catalase-21A\T (rs 7943316) gene in chronic myeloid leukemia patients infected with human herpes virus-7. Iraqi Journal of Hematology 2025; 14(1) doi: 10.4103/ijh.ijh_125_24
|
| 64 |
Mohamed El-Tanani, Hamdi Nsairat, Ismail I. Matalka, Yin Fai Lee, Manfredi Rizzo, Alaa A. Aljabali, Vijay Mishra, Yachana Mishra, Altijana Hromić-Jahjefendić, Murtaza M. Tambuwala. The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia. Pathology - Research and Practice 2024; 254 doi: 10.1016/j.prp.2024.155161
|
| 65 |
Tuward J. Dweh, Glay Jr Eric Wulu, John Kessellie Jallah, Dominic L. Miller, Jyoti Prakash Sahoo. Innovations in RNA therapeutics: a review of recent advances and emerging technologies. Nucleosides, Nucleotides & Nucleic Acids 2025; 44(12) doi: 10.1080/15257770.2025.2451377
|
| 66 |
Matthias Hoch, Wendy Weis, Felix Huth, Seshulatha Jamalapuram, Michelle Quinlan, Amarnath Bandaru, Suleyman Eralp Bellibas, Asmae Mirkou, Shruti Kapoor, Shefali Kakar. Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants. Clinical Pharmacology in Drug Development 2026; 15(2) doi: 10.1002/cpdd.1611
|
| 67 |
Andriy Grafov, Ana Flávia da Silva Chagas, Alice de Freitas Gomes, Wessal Ouedrhiri, Pierfrancesco Cerruti, Maria Cristina Del Barone, Breno de Souza Mota, Carlos Eduardo de Castro Alves, Anny Maíza Vargas Brasil, Antonia Maria Ramos Franco Pereira, Gemilson Soares Pontes. A Second Wind for Inorganic APIs: Leishmanicidal and Antileukemic Activity of Hydrated Bismuth Oxide Nanoparticles. Pharmaceutics 2024; 16(7) doi: 10.3390/pharmaceutics16070874
|
| 68 |
Sadegh Rajabi, Shokoofe Noori, Mohammad Reza Ashrafi, Mahsa Azami Movahed, Shabnam Farzaneh, Afshin Zarghi. Naringenin enhances anti-proliferation effect of 1-ferrocenyl-3-(4-methylsulfonylphenyl) propen-1-one on two different cells via targeting calmodulin signaling pathway. Molecular Biology Reports 2022; 49(2) doi: 10.1007/s11033-021-06923-8
|
| 69 |
Nabaneet Majumder, Sayandeep Nath. A Study of Hematological Malignancies in Tripura Medical College & Dr. BRAM Teaching Hospital. Journal of Evolution of Medical and Dental Sciences 2021; 10(31) doi: 10.14260/jemds/2021/502
|
| 70 |
Harpreet Singh, Arun Kumar Mishra, Vivek Kumar, Km Pinki, Arvind Kumar, Amrita Mishra, Amit Anand. Role of Biomarkers in Cancer Diagnosis and Therapeutics. 2026; doi: 10.1016/B978-0-443-44041-0.00006-4
|
| 71 |
Praveen Sharma, Man Updesh Singh Sachdeva, Shano Naseem, Sreejesh Sreedharanunni, Reena Das, Pankaj Malhotra, Neelam Varma. Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia. International Journal of Laboratory Hematology 2022; 44(3) doi: 10.1111/ijlh.13807
|
| 72 |
Marc Gonsalves, Andres Escobar, Ahmad Diaa Altarabishi, Chang-Qing Xu. Advances in Microflow Cytometry-Based Molecular Detection Methods for Improved Future MDS Cancer Diagnosis. Current Issues in Molecular Biology 2024; 46(8) doi: 10.3390/cimb46080476
|
| 73 |
Smeeta Gajendra, Leena Gupta, Deepshi Thakral, Ritu Gupta, Ranjit kumar Sahoo, Pramod Verma, Sangeeta Vashistha. Blurring the Lines: NPM1 Mutation in Blast Phase CML Challenges Traditional Paradigms. Indian Journal of Hematology and Blood Transfusion 2025; doi: 10.1007/s12288-025-02129-1
|
| 74 |
Macario Martínez-Castillo, Laura Gómez-Romero, Hugo Tovar, Irma Olarte-Carrillo, Anel García-Laguna, Gilberto Barranco-Lampón, Adrián De la Cruz-Rosas, Adolfo Martínez-Tovar, Araceli Hernández-Zavala, Emilio J. Córdova. Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia. Leukemia Research 2023; 131 doi: 10.1016/j.leukres.2023.107325
|